首页> 外文期刊>Anti-cancer agents in medicinal chemistry >CRISPR/Cas9 System and its Research Progress in Gene Therapy
【24h】

CRISPR/Cas9 System and its Research Progress in Gene Therapy

机译:CRISPR / CAS9系统及其在基因治疗中的研究进展

获取原文
获取原文并翻译 | 示例
           

摘要

Genome editing refers to changing the genome sequence of an organism by knockout, insertion, and site mutation, resulting in changes in the genetic information of the organism. The clustered regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein-9 nuclease (Cas9) system is a genome editing technique developed by the acquired immune system in the microbes, such as bacteria and archaebacteria, which targets and edits genome sequences according to the principle of complementary base pairing. This technique can be used to edit endogenous genomic DNA sequences in organisms accurately and has been widely used in fields, such as biotechnology, cancer gene therapy, and dermatology. in this review, we summarize the history, structure, mechanism, and application of CRISPR/Cas9 in gene therapy and dermatological diseases.
机译:基因组编辑是指通过敲除,插入和现场突变改变生物的基因组序列,导致生物体的遗传信息的变化。 聚集经常间隙的短语重复(CRISPR)/ CRISPR相关的蛋白-9核酸酶(CAS9)系统是由所获得的免疫系统在微生物(例如细菌和弓形曲)中开发的基因组编辑技术,其靶向和编辑基因组序列 互补基地配对原理。 该技术可用于精确地编辑生物体中的内源性基因组DNA序列,并已广泛应用于生物技术,癌症基因治疗和皮肤科。 在这篇综述中,我们总结了CRAP / CAS9在基因治疗和皮肤病疾病中的历史,结构,机制和应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号